Lab of Hematopoiesis and Leukemia, KSBS, Indian Institute of Technology, Delhi, New Delhi 110016, India; Cancer Immunology Lab, Department of Zoology, Banaras Hindu University, Varanasi 221005, India.
Cancer Immunology Lab, Department of Zoology, Banaras Hindu University, Varanasi 221005, India.
Life Sci. 2023 Oct 1;330:121999. doi: 10.1016/j.lfs.2023.121999. Epub 2023 Aug 1.
PKCα is a molecule with many functions that play an important role in cell survival and death to maintain cellular homeostasis. Alteration in the normal functioning of PKCα is responsible for the complicated etiology of many pathologies, including cancer, cardiovascular diseases, kidney complications, neurodegenerative diseases, diabetics, and many others. Several studies have been carried out over the years on this kinase's function, and regulation in normal physiology and pathological conditions. A lot of data with antithetical results have therefore accumulated over time to create a complex framework of physiological implications connected to the PKCα function that needs comprehensive elucidation. In light of this information, we critically analyze the multiple roles played by PKCα in basic cellular processes and their molecular mechanism during various pathological conditions. This review further discusses the current approaches to manipulating PKCα signaling amplitude in the patient's favour and proposed PKCα as a therapeutic target to reverse pathological states.
蛋白激酶 Cα(PKCα)是一种具有多种功能的分子,在维持细胞内环境稳定方面,对细胞存活和死亡起着重要作用。PKCα 的正常功能发生改变,是许多疾病(包括癌症、心血管疾病、肾脏并发症、神经退行性疾病、糖尿病等)复杂病因的根源。多年来,人们针对该激酶在正常生理和病理条件下的功能和调节进行了多项研究。因此,随着时间的推移,积累了大量相互矛盾的数据,从而形成了一个与 PKCα 功能相关的复杂生理影响框架,需要全面阐明。有鉴于此,我们批判性地分析了 PKCα 在各种病理条件下基本细胞过程中的多种作用及其分子机制。本综述进一步讨论了目前有利于患者的操纵 PKCα 信号幅度的方法,并提出 PKCα 作为逆转病理状态的治疗靶点。